TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design
